Clinigen Group (CLIN)

 

Latest News

Results of Court Meeting and General Meeting

RNS Number: 3891U Quantum Pharma PLC 23 October 2017 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES OF AMERICA) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVAN...

Form 8.3 - Clinigen Group plc

RNS Number: 3862U Victory Capital Management Inc. 23 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Victory Capit...

Form 8.3 - Clinigen Group Plc

Form 8.3 - Clinigen Group Plc Grandeur Peak Global Advisors, LLC FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the ?Code?) 1. KEY INFORMATION (a) Full name of discloser: ? Grandeur Peak ...

Form 8.3 - CLIN LN/QP LN

RNS Number: 3487U Syquant Capital 23 October 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/dealings are bei...

All News

DateHeadlineSource
23-10-17Results of Court Meeting and General MeetingRNS
23-10-17Form 8.3 - Clinigen Group plcRNS
23-10-17Form 8.3 - Clinigen Group PlcRNS
23-10-17Form 8.3 - QP LN/CLIN LNRNS
23-10-17Form 8.3 - CLIN LN/QP LNRNS
23-10-17Form 8.3 - Clinigen Group plcRNS
23-10-17Form 8.3 - Clinigen Group PLCRNS
23-10-17Form 8.3 -Clinigen Group PlcRNS
23-10-17Clinigen confirms terms of service with Quantum CEOStockMarketWire
23-10-17Clinigen acquires Japan's largest supplier of unlicensed medicinesStockMarketWire
23-10-17Clinigen acquires IMMC in JapanRNS
23-10-17Form 8.3 - Clinigen Group plcRNS
20-10-17Confirmation of terms of service with Chris RiggRNS
20-10-17Form 8.3 - QP LN/CLIN LNRNS
20-10-17Form 8.3 - CLIN LN/QP LNRNS
20-10-17Form 8.3 - Clinigen Group plcRNS
20-10-17Form 8.3 - [Clinigen Group plc]RNS
20-10-17Form 8.3 - Clinigen Group plcRNS
20-10-17Form 8.3 - Clinigen Group PlcRNS
20-10-17Form 8.3 - Clinigen Group PLCRNS
20-10-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
20-10-17Form 8.3 - Clinigen Group PlcRNS
20-10-17Form 8.3 - Clinigen Group PlcRNS
20-10-17Form 8.3 - Clinigen Group PlcRNS
20-10-17Form 8.3 - Clinigen Group PlcRNS
19-10-17Form 8.3 - Clinigen Group PlcRNS
19-10-17Form 8.3 - CLIN LN/QP LNRNS
19-10-17Form 8.3 - QP LN/CLIN LNRNS
19-10-17Form 8.3 - Clinigen Group plcRNS
19-10-17Form 8.3 - [Clinigen Group plc]RNS
19-10-17Form 8.3 - Clinigen Group PlcRNS
19-10-17Form 8.3 - Clinigen Group plcRNS
19-10-17Form 8.3 - Clinigen Group plcRNS
19-10-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
18-10-17Form 8.3 - CLIN LN/QP LNRNS
18-10-17Form 8.3 - QP LN/CLIN LNRNS
18-10-17Form 8.3 - Clinigen Group plcRNS
18-10-17Form 8.3 - Clinigen Group PLCRNS
18-10-17Form 8.3 - Clinigen Group PlcRNS
18-10-17Form 8.3 - [Clinigen Group plc]RNS

RSS feeds

  • Editorial news feed for LSE:CLIN Editorial
  • Regulatory news feed for LSE:CLIN Regulatory